EICHOR
● Completed
Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis
Condition: Moderate Plaque Psoriasis · Sponsor: Janssen Research & Development, LLC
About this study
The purpose of this study is to evaluate the efficacy of guselkumab compared to an inactive drug in participants with low body surface area moderate plaque psoriasis and special site involvement.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (64)
| Total Dermatology | Birmingham, Alabama, United States | — |
| Cahaba Research Inc | Birmingham, Alabama, United States | — |
| California Dermatology & Clinical Research Institute | Encinitas, California, United States | — |
| First OC Dermatology | Fountain Valley, California, United States | — |
| Practice Wang | Riverside, California, United States | — |
| Therapeutics Clinical Research | San Diego, California, United States | — |
| Rehlen, Bartlow, Goodman and Baron Dermatology Group | Santa Ana, California, United States | — |
| Clinical Science Institute | Santa Monica, California, United States | — |
| University of Conn Health Center | Farmington, Connecticut, United States | — |
| TrueBlue Clinical Research | Brandon, Florida, United States | — |
| Florida Academic Dermatology Centers | Coral Gables, Florida, United States | — |
| Revival Research | Doral, Florida, United States | — |
+ 52 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06039189